BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/9/2021 5:27:04 AM | Browse: 864 | Download: 2453
 |
Received |
|
2020-12-08 11:19 |
|
Peer-Review Started |
|
2020-12-08 11:20 |
|
First Decision by Editorial Office Director |
|
2021-01-11 02:04 |
|
Return for Revision |
|
2021-01-11 02:04 |
|
Revised |
|
2021-01-25 18:51 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-02-26 13:22 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-03-08 18:37 |
|
Articles in Press |
|
2021-03-08 18:37 |
|
Edit the Manuscript by Language Editor |
|
2021-03-18 09:06 |
|
Typeset the Manuscript |
|
2021-04-08 01:32 |
|
Publish the Manuscript Online |
|
2021-04-09 05:27 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pathology |
| Manuscript Type |
Basic Study |
| Article Title |
Vascular endothelial growth factor B inhibits insulin secretion in MIN6 cells and reduces Ca2+ and cyclic adenosine monophosphate levels through PI3K/AKT pathway
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Dan Jia, Wen-Guo Jiang, Xu Luo, Rong-Rong Li, Yu-Chi Zhao, Geng Tian and Ya-Na Li |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
31771284 |
| National Natural Science Foundation of China Youth Project |
31702024 |
| Major Basic Research Project of Shandong Provincial Natural Science Foundation |
ZR2019ZD27 |
| Shandong Province Higher Educational Science and Technology Plan Project |
J17KA258 |
|
| Corresponding Author |
Ya-Na Li, PhD, Associate Professor, Department of Pathophysiology, School of Basic Medicine, Binzhou Medical University, No. 346 Guanhai Road, Laishan District, Yantai 264003, Shandong Province, China. yaya-698@163.com |
| Key Words |
Type 2 diabetes; Insulin secretion; MIN6 cells; Vascular endothelial growth factor B; Blood glucose regulation |
| Core Tip |
Type 2 diabetes has elicited worldwide public health concerns, and mechanism regulating insulin secretion is unclear. We found that vascular endothelial growth factor B (VEGF-B) prevents MIN6 cells from secreting insulin through the PI3K-AKT (phosphatidylinositol 3-kinase-serine/threonine kinase) pathway. We have provided mechanistic insights into the effect of VEGF-B on insulin secretion and suggest VEGF-B as a new target that affects the occurrence and development of type 2 diabetes. |
| Publish Date |
2021-04-09 05:27 |
| Citation |
Jia JD, Jiang WG, Luo X, Li RR, Zhao YC, Tian G, Li YN. Vascular endothelial growth factor B inhibits insulin secretion in MIN6 cells and reduces Ca2+ and cyclic adenosine monophosphate levels through PI3K/AKT pathway. World J Diabetes 2021; 12(4): 480-498 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i4/480.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i4.480 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
